Warner Edmundson
Internal Medicine · Raleigh, NCNPI 1346382900
Payments from drug & device makers
Across 184 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$697
- Boehringer Ingelheim$534
- Amgen$319
- Novo Nordisk$298
- Paratek Pharmaceuticals, Inc.$168
- Merck$166
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,552100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 29 | $697 |
| Boehringer Ingelheim | 25 | $534 |
| Amgen | 14 | $319 |
| Novo Nordisk | 14 | $298 |
| Paratek Pharmaceuticals, Inc. | 4 | $168 |
| Merck | 12 | $166 |
| Pfizer | 11 | $161 |
| Johnson & Johnson | 12 | $158 |
| Novartis | 7 | $143 |
| Lilly USA, LLC | 8 | $129 |
| Eisai Inc. | 6 | $106 |
| AbbVie(2 entities) | 6 | $103 |
| Amarin Pharma, Inc. | 6 | $95 |
| Acadia Pharmaceuticals Inc | 5 | $91 |
| Daiichi Sankyo Inc. | 4 | $70 |
| GSK | 5 | $57 |
| Esperion Therapeutics, Inc. | 3 | $49 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Bausch Health US, LLC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Abbott | 1 | $20 |
| Biogen | 1 | $17 |
| Radius Health, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Gilead | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,564 in reported general payments places this provider in the 85th percentile of 3,302 internal medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $14,292 |
| JardianceEmpagliflozin | 23 | $10,862 |
| FarxigaDapagliflozin Propanediol | 16 | $4,094 |
| CombiganBrimonidine Tartrate/Timolol | 15 | $3,262 |
| Levothyroxine Sodium | 60 | $687 |
| Potassium Chloride | 38 | $630 |
| Mycophenolate Mofetil | 11 | $612 |
| Famotidine | 56 | $517 |
| Metoprolol Succinate | 43 | $419 |
| Atorvastatin Calcium | 46 | $387 |
| Esomeprazole Magnesium | 12 | $375 |
| Mirtazapine | 23 | $373 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 17 | $354 |
| Pantoprazole Sodium | 32 | $307 |
| Donepezil Hcl | 40 | $298 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $161 | $14,29225 claims |
| Boehringer IngelheimJardiance | $534 | $10,86223 claims |
| AstraZenecaFarxiga | $697 | $4,09416 claims |
| AbbVieCombigan | $103 | $3,26215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,302 internal medicine providers in North Carolina.
Other internal medicine in Raleigh
- John RubinoRaleigh$13M
- Wayne HarperRaleigh$6.7M
- Bhakti PaulRaleigh$536K
- Clifford CurtisRaleigh$376K
- Manesh PatelDurham$27.2M
- Saad UsmaniCharlotte$16.2M
- Christina KennellyCharlotte$15.4M
- Adam DevoreDurham$11.8M
- Krishnakumar UdayakumarDurham$11M
- Sylvia ShoffnerCary$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.